Black Swan Analysis

Maidenhead, United Kingdom Founded: 2007 • Age: 19 yrs Acquired By Evaluate
Provider of market analysis access, data analytics, and consulting services for pharmaceutical sector

About Black Swan Analysis

Black Swan Analysis is a Healthcare company based in Maidenhead (United Kingdom) founded in 2007, and was acquired by Evaluate in March 2020. Provider of market analysis access, data analytics, and consulting services for pharmaceutical sector. Its focus areas include Biopharma Outsourcing and Diversified.

Company details

Black Swan Analysis was established in 2007 in Maidenhead, United Kingdom. Services encompassing market analysis and access, data analytics, and consulting are delivered to the pharmaceutical sector. Operations are centered in the UK, with a focus on supporting industry stakeholders through data-driven insights and strategic advisory. The companys domain, blackswan-analysis.co.uk, facilitates access to these resources.

Key Metrics

Investors in Black Swan Analysis

Black Swan Analysis has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Evaluate.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Pharmaceutical market intelligence and forecasting solutions are provided by Evaluate.
1996evaluate.comLondon, United Kingdom
Premium access

Investor details for Black Swan Analysis

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Black Swan Analysis

2 dated milestones of Black Swan Analysis across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded Black Swan Analysis is founded.
  2. Exit Acquired by Evaluate.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Black Swan Analysis

Black Swan Analysis was founded in 2007.

Black Swan Analysis is headquartered in Maidenhead, United Kingdom.

Black Swan Analysis was established in 2007 in Maidenhead, United Kingdom. Services encompassing market analysis and access, data analytics, and consulting are delivered to the pharmaceutical sector. Operations are centered in the UK, with a focus on supporting industry stakeholders through data-driven insights and strategic advisory. The companys domain, blackswan-analysis.co.uk, facilitates access to these resources.

Black Swan Analysis has 1 investor. Key investors include Evaluate.

Yes. Black Swan Analysis was acquired by Evaluate in March 2020.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available